Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Leclerc, FR
Alain Leclerc, Houilles FR
| Patent application number | Description | Published |
|---|---|---|
| 20090283716 | Method for Producing a Fuel Cell Electrode, Involving Deposition on a Support - The invention relates to a method for producing carbon electrodes by deposition on a substrate, to produce a fuel cell. The method comprises the steps of alternately and/or simultaneously depositing porous carbon and a catalyst onto the substrate by plasma spaying in a vacuum chamber. The catalyst is used to accelerate at least one of the chemical reactions that takes place in the fuel cell. The thickness of each layer of porous carbon is chosen so that the catalyst deposited on this carbon layer is distributed essentially throughout this layer, thereby by providing a layer of catalyzed carbon. The total thickness of catalyzed carbon in the electrode is less than 2 micrometers, and preferably equal to no more than 1 micrometer. | 11-19-2009 |
Bernard Leclerc, Igny FR
| Patent application number | Description | Published |
|---|---|---|
| 20130039982 | LOW-DOSE TABLETS AND PREPARATION PROCESS - The invention concerns a microgranule tablet comprising a low dose of active principle containing a directly compressible diluent. The invention is characterised in that the directly compressible diluent consists exclusively of neutral microgranules, and the active principle is set on the neutral microgranules and is not coated with an agent designed to modify its release or mask its taste. | 02-14-2013 |
Brice Leclerc, Arpajon FR
| Patent application number | Description | Published |
|---|---|---|
| 20090300689 | Method for transmitting broadcast services in a radiocommunication cellular network through a femto base station, and corresponding femto base station - The invention concerns a method and a Femto base station for transmitting broadcast services from a radiocommunication cellular network ( | 12-03-2009 |
| 20100323741 | METHOD AND EQUIPMENT FOR MANAGING THE ATTACHMENT PROCESS OF A MOBILE EQUIPMENT TO A BASE STATION - The present invention refers to a method for managing the attachment process of a mobile equipment to a base station wherein the attachment process is configured by a call from the mobile equipment toward the line to which said base station is connected. | 12-23-2010 |
Brice Leclerc, Nozay FR
| Patent application number | Description | Published |
|---|---|---|
| 20100015950 | Method for managing a telecommunication network and associated devices - The invention pertains to a method for managing a telecommunication network, comprising at least one base station in which said at least one base station is located and authenticated through the use of at least one identification parameter for a landline of the telecommunication network to which the base station is connected. | 01-21-2010 |
| 20110269467 | METHOD FOR MANAGING RADIO LINKS WITHIN A RADIO COMMUNICATION SYSTEM WITH MOBILE UNITS, AND EQUIPMENT ADAPTED TO IMPLEMENTING THE METHOD - In an access network infrastructure of a cellular radio communication network, comprising a first radio access point serving at least one radio cell and capable of communicating, over a radio interface, with at least one user equipment item located within the radio coverage of at least one of the radio cells, first and second criteria for establishing a radio communication link with a radio access point are defined, with these two criteria being distinct from one another, as well as a set of user equipment associated with the first radio access point. Whenever user equipment is located within the radio coverage of at least one of the cells of the first radio access point, and the first criterion for establishing a radio communication link or the second criterion for establishing a radio communication link is applied, depending on whether or not the user equipment belongs to the set of user equipment associated with the first radio access point, for the purposes of establishing a radio communication link between the user equipment and the first radio access point whenever the applied radio communication link establishment criterion is fulfilled. | 11-03-2011 |
| 20120115467 | METHOD FOR MANAGING THE OPERATION OF A RADIO ACCESS POINT OF AN ACCESS NETWORK INFRASTRUCTURE OF A RADIO COMMUNICATION NETWORK - In a radio communication network access network infrastructure, comprising first and second access points into the access network infrastructure which are both capable of communicating over a radio interface with a user equipment, wherein the radio coverage of the first access point is at least partially included in the radio coverage of the second access point, and wherein the first access point is capable of operating in an operating mode wherein it does not transmit a pilot signal, the first access point synchronizes itself with the second access point during reception, and switches to the operating mode wherein it does not transmit a pilot signal. | 05-10-2012 |
| 20120127260 | Videoconferencing Communication Device And Method - The device for videoconferencing between a local user ( | 05-24-2012 |
Christian Leclerc, Dun-Sur-Auron FR
| Patent application number | Description | Published |
|---|---|---|
| 20080206412 | Supplementary Food Compositions - A supplementary food composition comprising at least one organic mineral salt that contributes to alkaline power in a quantity ranging from 20 to 200 mEq and is capable of neutralizing an acidic charge of 20 to 200 mEq of H | 08-28-2008 |
| 20100323080 | FOOD COMPOSITIONS FOR SALTING IN PARTICULAR - The application relates, in particular, to a salting composition comprising at least two potassium salts at least one of which is a potassium organic salt. The application likewise relates to a method of preparing a food product comprising at least one step consisting of adding said composition to a food product. Finally, the application also relates to the use of said composition as a salting agent. | 12-23-2010 |
Christophe Leclerc, Elbeuf Sur Seine FR
| Patent application number | Description | Published |
|---|---|---|
| 20110229624 | PROCESS AND PRODUCT - A process for producing an inclusion comprising extruding a mixture of at least 20% sugar with at least 25% cocoa powder or at least 10% cocoa cake or at least 10% of a combination of cocoa powder and cocoa cake. An inclusion obtainable by this process. An extruded inclusion comprising at least 20% sugar with at least 25% cocoa powder or at least 10% cocoa cake or at least 10% of a combination of cocoa powder and cocoa cake. | 09-22-2011 |
Christophe Leclerc, Poligny FR
| Patent application number | Description | Published |
|---|---|---|
| 20080318174 | Gas burner for oven - Burner for gas oven comprising a device for retaining a flame of the burner, separating the flame from a mixing chamber capable of receiving a flow of primary air and gas to form a gaseous mixture. The flame retention device is provided with a mesh comprising metal threads, capable of allowing said gaseous mixture to pass through the mesh, said mesh comprising at least one main zone and a pilot zone which are adjacent. The pilot zone having, according to a main direction of the flame of the burner, a thickness greater than the thickness of the main zone, capable of slowing down the gaseous mixture passing through the pilot zone relative to the mixture passing through the main zone. The burner comprises at least one orifice capable of receiving a secondary air flow. | 12-25-2008 |
Claude Leclerc, Paris Cedex FR
| Patent application number | Description | Published |
|---|---|---|
| 20110268757 | USE OF PHENOL-SOLUBLE MODULINS FOR VACCINE DEVELOPMENT - The invention relates to methods for increasing immunogenicity of an antigenic peptide by means of its covalent coupling to a modulin derived peptide (PSM, phenol soluble modulin). In particular, the binding of PSMα, PSMγ and PSMδ peptides to an antigen (from a pathogen or a tumor associated protein) increases the capacity of the antigen to activate an immune response in vivo. Thus, the PSMα, PSMγ and PSMδ peptides bound to these antigens may be used in the development of vaccines for preventing or treating infectious diseases or cancer | 11-03-2011 |
Claude Leclerc, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20090117143 | Recombinant adenylate cyclase toxin of bordetella induces T cell responses against tumoral antigens - An immunogenic composition comprising a recombinant protein comprising a | 05-07-2009 |
| 20090220532 | Agents and methods based on the use of the eda domian of fibronectin - This invention relates to the use of a polypeptide in the production of an immunostimulatory agent, said polypeptide comprising a sequence corresponding to the EDA domain of fibronectin, a fragment of the EDA domain which can bind to TLR4 or a variant of said EDA domain or a fragment which can bind to TLR4 and which has a homology of more than 70% with any form or natural fragment of the EDA domain. The invention also relates to the production methods and applications of said agent. | 09-03-2009 |
| 20090317854 | Recombinant adenylate cyclase of BORDETELLA SP. for diagnostic and immunomonitoring uses, method of diagnosing or immunomonitoring using said recombinant adenylate cyclase, and kit for diagnosing or immunomonitoring comprising said recombinant adenylate cyclase - Diagnostic testing and immunomonitoring that uses genetically detoxified | 12-24-2009 |
| 20100150999 | THERAPY OF CANCER BASED ON TARGETING ADAPTIVE, INNATE AND/OR REGULATORY COMPONENT OF THE IMMUNE RESPONSE - The invention relates to a kit of parts, suitable for use in a therapy of cancer, wherein said kit comprises: (i) a recombinant protein comprising one or several polypeptides bearing one or several epitopes of one or several tumor-associated antigens, said polypeptides being inserted in the same or different permissive sites of an adenylate cyclase (CyaA) protein or of a fragment thereof, wherein said CyaA fragment retains the property of said adenylate cyclase protein to target Antigen Presenting Cells or a mixture of such recombinant proteins wherein at least one of said epitopes, or tumor associated antigens, or insertion sites of CyaA protein, or fragment of said CyaA protein is different between the various recombinant proteins in the mixture; and said kit of parts further comprises at least one of the following compounds; (ii) an agent, suitable for modulating a regulatory immune response in a patient ad optionally; (iii) an adjuvant component suitable for activating the innate immune response in a patient. | 06-17-2010 |
| 20100239550 | MUTANT CyaA POLYPEPTIDES AND POLYPEPTIDE DERIVATIVES SUITABLE FOR THE DELIVERY OF IMMUNOGENIC MOLECULES INTO A CELL - The invention relates to mutant CyaA/E570Q+K860 polypeptides suitable for use as proteinaceous vectors for delivering one or more molecules of interest into a cell, in particular into a cell expressing the CD11b receptor. The invention further relates to polypeptide derivatives suitable for eliciting an immune response in a host. | 09-23-2010 |
| 20100272707 | ENZYMATIC LARGE-SCALE SYNTHESIS OF MUCIN GLYCONJUGATES, AND IMMUNOGENIC APPLICATIONS THEREOF - The present invention relates to mucin glycoconjugates, and to a process of producing mucin glycoconjugates. It relates to the biological, pharmaceutical and medical applications thereof. The invention notably provides mucin glycoconjugates which do not require a protein carrier, such as KHL, to induce an immune response (anti-Tn IgG). | 10-28-2010 |
| 20100310594 | RECOMBINANT ADENYLATE CYCLASE TOXIN OF BORDETELLA INDUCES T CELL RESPONSES AGAINST TUMORAL ANTIGENS - An immunogenic composition comprising a recombinant protein comprising a | 12-09-2010 |
| 20110171244 | RECOMBINANT PROTEIN CARRYING HUMAN PAPILLOMAVIRUS EPITOPES INSERTED IN AN ADENYLATE CYCLASE PROTEIN OR FRAGMENT THEREOF THERAPEUTIC USES THEREOF - The invention relates to a recombinant protein comprising one or several polypeptides bearing one or several epitopes of one or several HPV antigens, said polypeptides being inserted in the same or different permissive sites of an adenylate cyclase (CyaA) protein or of a fragment thereof, wherein said CyaA fragment retains the property of said adenylate cyclase protein to target Antigen Presenting Cells. It also concerns polynucleotides encoding the same. The recombinant protein or the polynucleotide can be used for the design of therapeutic means against HPV infection or against its malignant effects. | 07-14-2011 |
| 20120071393 | Mutant CyaA Polypeptides and Polypeptide Derivatives Suitable for the Delivery of Immunogenic Molecules Into a Cell - The invention relates to mutant CyaA/E570Q+K860 polypeptides suitable for use as proteinaceous vectors for delivering one or more molecules of interest into a cell, in particular into a cell expressing the CD11b receptor. The invention further relates to polypeptide derivatives suitable for eliciting an immune response in a host. | 03-22-2012 |
| 20120189662 | Identification of virulence associated regions RD1 and RD5 leading to improve vaccine of M. bovis BCG and M. microti - The present invention relates to a strain of | 07-26-2012 |
| 20120214206 | VECTORS FOR MOLECULE DELIVERY TO CD11b EXPRESSING CELLS - The invention relates to a novel use of a | 08-23-2012 |
Delphine Leclerc, Cosne Sur Loire FR
| Patent application number | Description | Published |
|---|---|---|
| 20100314813 | HIGHLY DAMPING EXPANDABLE MATERIAL AND DEVICES - A thermally expandable material comprising a first thermoplastic elastomer having a first glass transition temperature, a second thermoplastic elastomer having a second glass transition temperature, wherein the first and the second glass transition temperature differ by at least 10° C.; at least one thermoplastic polymer selected from the group consisting of polymers and copolymers with at least one polymerizable C═C double bond, optionally at least one tackifying resin, at least one latent chemical blowing agent in an amount effective to cause the expandable material to expand at least 50% in volume when heated. | 12-16-2010 |
| 20110024933 | EXPANDABLE FILLER INSERT AND METHODS OF PRODUCING THE EXPANDABLE FILLER INSERT - A carrier-free expandable filler insert for filling or sealing a hollow space or cavity is provided. The insert comprises a self-supporting continuous structure that may be produced by contour extrusion molding or injection molding a polymer matrix containing a polymer and/or polymer precursor and a latent blowing agent. The expandable filler insert is secured to the interior surface of a vehicle pillar, for example, using a fixing element that may be integral with the self-supporting continuous structure, the polymer matrix thereafter being activated and expanded by heating. | 02-03-2011 |
Denis Leclerc, Igny FR
| Patent application number | Description | Published |
|---|---|---|
| 20090119360 | CONDITION CONTROL SYSTEM, DEVICE AND PROCESS FOR MESSAGE TRANSMISSION - The invention concerns in particular a system comprising: a first terminal ( | 05-07-2009 |
Eric Leclerc, Margny Les Compiegne FR
| Patent application number | Description | Published |
|---|---|---|
| 20130060550 | METHOD OF TOXICOLOGICAL EVALUATION, METHOD OF TOXICOLOGICAL SCREENING AND ASSOCIATED SYSTEM - The present invention relates to a method of toxicological evaluation of a candidate substance on at least one tissue or organ, characterized in that it comprises the steps of: (a) obtaining a bioartificial tissue or organ by simulation or modelling of the metabolic activity of said tissue or organ by at least one bioreactor; (b) exposure of said bioartificial tissue or organ to said substance; (c) observation of the metabolic response of the bioartificial tissue or organ and acquisition without a priori of an associated multidimensional data set; (d) identification by means of a method of multivariate statistical analysis of the components of the multidimensional data set which are quantitatively correlated with predetermined variables; (e) generation of a predictive model on the basis of the components of the data set that are actually retained; (f) testing of the predictive nature of said model by at least one statistical method of estimating reliability; (g) identification of the metabolic response of the bioartificial tissue or organ in the form of biomarkers associated with the components of the data set that are adopted for the model. The present invention also relates to a method of toxicological screening and to a system for this purpose. | 03-07-2013 |
Frederic Leclerc, Grenoble FR
| Patent application number | Description | Published |
|---|---|---|
| 20080303510 | Optical Sensor Arrangement for Electrical Switchgear - An optical sensor configuration contains an optical current sensor and/or an optical voltage sensor. The sensor configuration further contains a first and a second hollow member, preferably ring shaped profiles, which are together disposed to form a hollow section. The sensor configuration further includes an optical fiber of the current sensor disposed in an annular groove, the groove being disposed at the boundary surface between the first hollow member and the second hollow member, and/or an optical fiber of the voltage sensor is disposed in a recess of the second hollow member. The first hollow member has an annular recess into which the second hollow member is disposed whereas the first hollow member is an L-shaped or U-shaped ring with two legs and the recess is formed between the two legs. | 12-11-2008 |
Guyselaine Leclerc, Maisse FR
| Patent application number | Description | Published |
|---|---|---|
| 20110301376 | PREPARATION OF CRYSTALLINE EZATIOSTAT HYDROCHLORIDE ANSOLVATE FORM D - Provided herein are processes of preparing ezatiostat hydrochloride, and crystalline ezatiostat hydrochloride ansolvate form D. | 12-08-2011 |
Jacques Leclerc, Valence FR
| Patent application number | Description | Published |
|---|---|---|
| 20120096944 | DEVICE FOR MEASURING PRESSURE, AND METHOD FOR MANUFACTURING SAME - Device for measuring pressure through the capacitive effect between two electrodes including at least one sensitive electrode spaced apart from and opposite a stationary electrode so as to define a cavity in which a reference pressure (Pref) exists. The device in accordance with the invention further includes a protective housing for insulating at least the stationary electrode from the ambient environment in which the pressure to be measured exists, the housing having at least one solid portion forming a recess for containing at least the stationary electrode, and a thinned portion forming the sensitive electrode. | 04-26-2012 |
Michel Leclerc, Limas FR
| Patent application number | Description | Published |
|---|---|---|
| 20090174397 | INTERNAL INSTRUMENTATION SYSTEM FOR A NUCLEAR REACTOR, THE SYSTEM HAVING AN ADVANCED ELECTRONIC CARD, AND A CORRESPONDING METHOD OF MODIFYING AN INTERNAL INSTRUMENTATION SYSTEM OF A NUCLEAR REACTOR - This internal instrumentation system ( | 07-09-2009 |
Nathalie Leclerc, Bionville Sur Nied FR
| Patent application number | Description | Published |
|---|---|---|
| 20100252442 | METHOD AND DEVICE FOR SELECTIVE CATION EXTRACTION BY ELECTROCHEMICAL TRANSFER IN SOLUTION AND APPLICATIONS OF SAID METHOD - In order to carry out a selective extraction of cations (M | 10-07-2010 |
Odile Leclerc, Massy FR
| Patent application number | Description | Published |
|---|---|---|
| 20090054416 | 1,4-Diazabicyclo[3.2.2]nonanecarboxamide Derivatives, Preparation and Therapeutic Use Thereof - The present invention discloses and claims compounds of general formula | 02-26-2009 |
| 20090088440 | DERIVATIVES OF 5-PYRIDAZINYL-1-AZABICYCLO[3.2.1]OCTANE, PREPARATION METHOD THEREOF AND USE OF SAME IN THERAPEUTICS - The invention relates to compounds having general formula (I), wherein R is as defined herein. | 04-02-2009 |
| 20100035916 | AZABICYCLOALKANE DERIVATIVES, PREPARATION THEREOF AND USE THEREOF IN THERAPY - The invention relates to compounds of the general formula (I): | 02-11-2010 |
| 20110009444 | N-AZABICYCLIC CARBOXAMIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF - This disclosure relates to compounds of formula (I): | 01-13-2011 |
| 20110077264 | DERIVATIVES OF 5-PYRIDINYL-1-AZABICYCLO[3.2.1]OCTANE, PREPARATION METHOD THEREOF AND USE OF SAME IN THERAPEUTICS - The invention relates to compounds having general formula (I), wherein R is as defined herein. | 03-31-2011 |
| 20120046298 | DERIVATIVES OF 5-PYRIDAZINYL-1-AZABICYCLO[3.2.1]OCTANE, PREPARATION METHOD THEREOF AND USE OF SAME IN THERAPEUTICS - The invention relates to compounds having general formula (I), wherein R is as defined herein. | 02-23-2012 |
| 20120202807 | AZABICYCLOALKANE DERIVATIVES, PREPARATION THEREOF AND USE THEREOF IN THERAPY - The invention relates to compounds of the general formula (I): | 08-09-2012 |
Pascal Leclerc, Orsay FR
| Patent application number | Description | Published |
|---|---|---|
| 20110050469 | LINE OF PROPAGATION DIGITIZING DEVICE - An electric signal digitizing device includes a line of propagation through which the signal travels and a plurality of samplers ( | 03-03-2011 |
Thomas Leclerc, Lyon FR
| Patent application number | Description | Published |
|---|---|---|
| 20100220919 | Method and installation for detecting foreign bodies inside a container - The invention relates to an installation for detecting the presence of a foreign body ( | 09-02-2010 |
Veronique Leclerc, Avelin FR
| Patent application number | Description | Published |
|---|---|---|
| 20090239917 | Heterocyclic Cycloalkyl Compounds, a Process for their Preparation and Pharmaceutical Compositions Containing Them - Compounds of formula (I): | 09-24-2009 |